Innovate is a publicly traded (Nasdaq: INNT) clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases with unmet needs. Our pipeline includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis. Innovate is led by a strong management team with extensive drug development experience and a history of bringing novel therapeutics to market. All global rights to the products, which are backed by more than 150 patents worldwide, are owned by the company.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
INN-202 for celiac disease
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):